Stability of bacteriophages in organic solvents for formulations

被引:6
作者
Cao, Yue [1 ]
Khanal, Dipesh [1 ]
Kim, Jinhee [2 ]
Chang, Rachel Yoon Kyung [1 ]
Byun, Alex Seungyeon [1 ]
Morales, Sandra [3 ]
Holl, Mark M. Banaszak [4 ,5 ]
Chan, Hak-Kim [1 ,6 ]
机构
[1] Univ Sydney, Fac Med & Hlth, Sydney Pharm Sch, Adv Drug Delivery Grp, Sydney, NSW 2006, Australia
[2] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA
[3] Phage Consulting, Sydney, NSW 2100, Australia
[4] Univ Alabama Birmingham, Dept Mech & Mat Engn, Birmingham, AL 35294 USA
[5] Univ Alabama Birmingham, Heersink Sch Med, Div Pulmonol Allergy & Crit Care Med, Birmingham, AL 35294 USA
[6] Univ Sydney, S341,Pharm & Bank Bldg A15, Sydney, NSW 2006, Australia
关键词
Bacteriophage (phage); Organic solvents; Phage formulation; Phage stability; Pseudomonas aeruginosa; Spectroscopy; PROTEIN; INACTIVATION; NEBULIZATION;
D O I
10.1016/j.ijpharm.2023.123505
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Bacteriophages or phages used as an alternative therapy for treating multi-drug resistant infections require formulation consideration. Current strategies to produce phage formulations involving organic solvents are based on empirical practices without a good understanding of phage stability during formulation development. In this study, we investigated the effect of common formulation organic solvents (ethanol, isopropyl alcohol, tetrahydrofuran (THF) and dimethyl sulfoxide (DMSO)) on the stability of Pseudomonas aeruginosa-specific myovirus (PEV1, PEV20) and podovirus (PEV31) phages using biological assay, transmission electron microscopy (TEM) and scattering near field optical microscopy (SNOM). The three phages were mixed with the solvents at different concentrations (25%, 50%, and 75% (v/v)) for 20 min. All phages were fully viable in the organic solvents at 25% (v/v) showing negligible titre changes. At the higher solvent concentration of 50% (v/v), the myoviruses PEV1 and PEV20 remained relatively stable (titre loss 0.4-1.3 log10), whereas the podovirus PEV31 became less stable (titre loss 0.25-3.8 log10), depending on the solvent used. Increasing the solvent level to 75% (v/v) caused increased morphological changes in TEM and decreased viability as indicated by the titre loss (0.32-7.4 log10), with DMSO being the most phage-destabilising solvent. SNOM spectra showed differences in the signal intensity and peak positions in the amide I and amide II regions, revealing altered phage proteins by the solvents. In conclusion, the choice of the solvents for phage formulation depends on both the phages and solvent types. Our results showed (1) the phages are more stable in the alcohols than DMSO and THF, and (2) the myoviruses tend to be more stable than the podovirus in the solvents. Overall, a low to moderate (25-50 % v/v) level of organic solvents (except 50% THF) can be used in formulation of the phages without a substantial titre loss.
引用
收藏
页数:10
相关论文
共 49 条
[31]   Microfluidic-assisted bacteriophage encapsulation into liposomes [J].
Leung, Sharon S. Y. ;
Morales, Sandra ;
Britton, Warwick ;
Kutter, Elizabeth ;
Chan, Hak-Kim .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 545 (1-2) :176-182
[32]   Jet nebulization of bacteriophages with different tail morphologies - Structural effects [J].
Leung, Sharon Shui Yee ;
Carrigy, Nicholas B. ;
Vehring, Reinhard ;
Finlay, Warren H. ;
Morales, Sandra ;
Carter, Elizabeth A. ;
Britton, Warwick J. ;
Kutter, Elizabeth ;
Chan, Hak-Kim .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 554 :322-326
[33]   Microfluidic platform for the real time measurement and observation of endothelial barrier function under shear stress [J].
Lewis, Daniel M. ;
Mavrogiannis, Nicholas ;
Gagnon, Zachary ;
Gerecht, Sharon .
BIOMICROFLUIDICS, 2018, 12 (04)
[34]   Formulation, stabilisation and encapsulation of bacteriophage for phage therapy [J].
Malik, Danish J. ;
Sokolov, Ilya J. ;
Vinner, Gurinder K. ;
Mancuso, Francesco ;
Cinquerrui, Salvatore ;
Vladisavljevic, Goran T. ;
Clokie, Martha R. J. ;
Garton, Natalie J. ;
Stapley, Andrew G. F. ;
Kirpichnikova, Anna .
ADVANCES IN COLLOID AND INTERFACE SCIENCE, 2017, 249 :100-133
[35]   Design of a Small-Scale Multi-Inlet Vortex Mixer for Scalable Nanoparticle Production and Application to the Encapsulation of Biologics by Inverse Flash NanoPrecipitation [J].
Markwalter, Chester E. ;
Prud'homme, Robert K. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (09) :2465-2471
[36]  
Moghimian P., 2016, J. Biomater. Nanobiotechnol, V07, P72
[37]   Filamentous bacteriophage stability in non-aqueous media [J].
Olofsson, L ;
Ankarloo, J ;
Andersson, PO ;
Nicholls, IA .
CHEMISTRY & BIOLOGY, 2001, 8 (07) :661-671
[38]   A freeze-dried formulation of bacteriophage encapsulated in biodegradable microspheres [J].
Puapermpoonsiri, U. ;
Spencer, J. ;
van der Walle, C. F. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 72 (01) :26-33
[39]   Bacteriophage T4 Head: Structure, Assembly, and Genome Packaging [J].
Rao, Venigalla B. ;
Fokine, Andrei ;
Fang, Qianglin ;
Shao, Qianqian .
VIRUSES-BASEL, 2023, 15 (02)
[40]   Improved Application of Carbon Nanotube Atomic Force Microscopy Probes Using PeakForce Tapping Mode [J].
Slattery, Ashley D. ;
Shearer, Cameron J. ;
Shapter, Joseph G. ;
Blanch, Adam J. ;
Quinton, Jamie S. ;
Gibson, Christopher T. .
NANOMATERIALS, 2018, 8 (10)